Literature DB >> 7350898

Comparison of the pattern and diffuse-light visual evoked responses in definite multiple sclerosis.

W B Wilson, R B Keyser.   

Abstract

We prospectively studied 100 patients with "definite" multiple sclerosis to determine which of three methods of stimulation most consistently had results that disclosed abnormalities in the visual evoked response when they were compared with those from normal controls. The three methods were diffuse flashes of light, intermittent reversing pattern, and constant luminous but reversing pattern. The most sensitive indicator of abnormality of the visual evoked response was the latency of the major occipital positive peak. Virtually no difference was evident between the results from the two methods of pattern stimulation. Of only slightly less sensitivity was the latency of the major positive peak with diffuse-light stimulation, and this showed a prolonged latency in a greater number of patients when visual acuity was poor. Abnormalities of latency of the first negative peak and of amplitude were not related to the clinical expression of the multiple sclerosis, whether relapsing, progressive, or relapsing and progressive.

Entities:  

Mesh:

Year:  1980        PMID: 7350898     DOI: 10.1001/archneur.1980.00500500060008

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Discriminative power of visual evoked potential characteristics in multiple sclerosis.

Authors:  M H Cuypers; K Dickson; A J Pinckers; J M Thijssen; O R Hommes
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

2.  Pattern-onset visual evoked potentials in suspected multiple sclerosis.

Authors:  M J Aminoff; A L Ochs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-07       Impact factor: 10.154

3.  Visual evoked potentials and CSF IgG at different stages of multiple sclerosis: a possible correlation.

Authors:  R Capparelli; D Inzitari; L Amaducci; D Baroncelli; M C Boschi; R Frosini
Journal:  Ital J Neurol Sci       Date:  1983-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.